Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis. Reply

Howard Trachtman; Michelle N. Rheault; Radko Komers

doi:10.1056/nejmc2401126

Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis. Reply

Howard Trachtman, Michelle N. Rheault, Radko Komers

Pediatric Nephrology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1154-1155
Number of pages	2
Journal	The New England journal of medicine
Volume	390
Issue number	12
DOIs	https://doi.org/10.1056/nejmc2401126
State	Published - Mar 21 2024

PubMed: MeSH publication types

Letter
Comment

Publisher link

10.1056/nejmc2401126

Find It

Find It at U of M Libraries

Cite this

@article{03d390b999d24e428e4e5e5746c16d5f,

title = "Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis. Reply",

author = "Howard Trachtman and Rheault, \{Michelle N.\} and Radko Komers",

year = "2024",

month = mar,

day = "21",

doi = "10.1056/nejmc2401126",

language = "English (US)",

volume = "390",

pages = "1154--1155",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "12",

}

TY - JOUR

T1 - Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis. Reply

AU - Trachtman, Howard

AU - Rheault, Michelle N.

AU - Komers, Radko

PY - 2024/3/21

Y1 - 2024/3/21

UR - https://www.scopus.com/pages/publications/85188497451

UR - https://www.scopus.com/inward/citedby.url?scp=85188497451&partnerID=8YFLogxK

U2 - 10.1056/nejmc2401126

DO - 10.1056/nejmc2401126

M3 - Letter

C2 - 38507769

AN - SCOPUS:85188497451

SN - 0028-4793

VL - 390

SP - 1154

EP - 1155

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 12

ER -

Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis. Reply

PubMed: MeSH publication types

Publisher link

Find It

Other files and links

Cite this